Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Early research (Phase 1)Ended earlyNCT02212730
What this trial is testing

A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)

Who this might be right for
Renal Cell Cancer
Merck Sharp & Dohme LLC 10
Not applicableUnknownNCT01105364
What this trial is testing

Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer

Who this might be right for
Kidney CancerMetastatic Cancer
National Cancer Institute, France 50
Not applicableLooking for participantsNCT05287464
What this trial is testing

International Multicentric Study ARON-1

Who this might be right for
Metastatic Renal Cell Carcinoma (mRCC)
Hospital of Macerata 1,220
Not applicableStudy completedNCT05012865
What this trial is testing

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

Who this might be right for
Renal Cell Carcinoma
Pfizer 48
Not applicableEnrolling By InvitationNCT06145139
What this trial is testing

KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational Trial

Who this might be right for
Renal Cancer
University of Aarhus 500
Not applicableNot Yet RecruitingNCT07243067
What this trial is testing

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

Who this might be right for
Renal Cell CarcinomaClear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+2 more
Mayo Clinic 300
Early research (Phase 1)Study completedNCT00348699
What this trial is testing

AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Ovarian Epithelial Cancer+7 more
National Cancer Institute (NCI) 68
Early research (Phase 1)Study completedNCT01202032
What this trial is testing

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Centre Leon Berard 36
Not applicableStudy completedNCT03748901
What this trial is testing

PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

Who this might be right for
Renal Cell Carcinoma
Chugai Pharmaceutical 830
Not applicableEnrolling By InvitationNCT07046832
What this trial is testing

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

Who this might be right for
OncologyInterventional RadiologyLiver Carcinoma+2 more
MediView XR, Inc. 104
Testing effectiveness (Phase 2)Ended earlyNCT01806064
What this trial is testing

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Tracon Pharmaceuticals Inc. 173
Not applicableStudy completedNCT03699579
What this trial is testing

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

Who this might be right for
Renal Cell Carcinoma MetastaticRenal Cell Carcinoma
Ipsen 28
Not applicableStudy completedNCT07713654
What this trial is testing

Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study

Who this might be right for
Kidney Cancers
University of Zurich 9
Testing effectiveness (Phase 2)Ended earlyNCT00417677
What this trial is testing

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Wyeth is now a wholly owned subsidiary of Pfizer 124
Testing effectiveness (Phase 2)Study completedNCT00056095
What this trial is testing

Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
UNICANCER 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06472895
What this trial is testing

AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 30
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT00830895
What this trial is testing

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Seoul National University Hospital 49
Testing effectiveness (Phase 2)Study completedNCT01775930
What this trial is testing

Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 10
Next Page